These findings demonstrate that miR-4454 downregulation can, at least partially, account for GNL3L overexpression in colon cancer and provide important insights into the mechanisms underlying GNL3L overexpression in chemoresistant CRC. The gene discussed is GNL3L; the disease is malignant colon neoplasm.